The Scientist

» drug development, evolution and ecology

Most Recent

image: Cheetah Range Drops 90 Percent

Cheetah Range Drops 90 Percent

By | December 27, 2016

Estimating only 7,100 individuals remaining, researchers urge a reclassification of the species from vulnerable to endangered.

0 Comments

Standard taxonomy lumps together bird species that should be separate, a new study suggests, raising the total number of estimated species from 9,000 to 18,000.

1 Comment

image: A Tale of Two Tails

A Tale of Two Tails

By | December 7, 2016

An analysis of ancient fish fossils suggests that mammalian and fish tails are fundamentally different structures, each with unique evolutionary histories.

1 Comment

image: Trumping Science: Part II

Trumping Science: Part II

By | December 6, 2016

As Inauguration Day nears, scientists and science advocates are voicing their unease with the Trump Administration’s potential effects on research.

2 Comments

image: Biomedical Research Bill Approved in House

Biomedical Research Bill Approved in House

By | December 1, 2016

The 21st Century Cures Act could provide funds to federal research agencies for the decade and accelerate the drug approval process.

1 Comment

Scientists are enlisting the help of pigeons, parrots, crows, jays, and other species to disprove the notion that human cognitive abilities are beyond those of other animals.

3 Comments

Spruce and pine and have relied on similar genetic toolkits for climate adaptation despite millions of years of evolution.

0 Comments

image: Elephant Footprints Create Habitat for Tiny Aquatic Creatures

Elephant Footprints Create Habitat for Tiny Aquatic Creatures

By | December 1, 2016

Researchers discover diverse communities of invertebrates inhabiting the water-filled tracks of elephants in Uganda.

0 Comments

A family’s collection of antique microscope slides became a trove of genetic information about the eradicated European malaria pathogen.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS